Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
News
Overview
Overview
Home
UK Shares
UK SHARES
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
MARKET DATA
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
FUNDS
Funds Centre
Managers
News
Brokers
BROKERS
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
SPREAD BET
Learn
Strategies
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist
Pharmaceuticals & Biotechnology (NMX4570)
22,562.31
17:09 14/03/25
0.73%
162.49
High / Low
22,606.08 / 22,339.21
Open / Close
22,399.82 / 22,562.31
Advertising
News
Overview
Latest webfg news
GSK 5-in1 meningitis drug gets US approval
17 Feb
UBS ups rating on AstraZeneca to 'buy'
13 Feb
London close: Stocks mixed as US inflation comes in hot
12 Feb
Ixico upbeat on breakthrough with AI imaging platform
12 Feb
Morgan Stanley sees huge upside at AstraZeneca
12 Feb
Indivior flags delay to FDA review of Sublocade label change
12 Feb
Agronomics investee Meatly launches cultivated meat dog treat
07 Feb
Revenues, profits surge at AstraZeneca
06 Feb
London close: Stocks rise as trade tensions continue
05 Feb
hVIVO reports positive results from Shionogi RSV trial
05 Feb
GSK ups five-year sales outlook, unveils $2bn buyback
05 Feb
Pfizer beats Q4 forecasts, posts weaker outlook
04 Feb
ValiRx's Inaphaea inks deal with UK-based Screenin3D
03 Feb
Revenue higher, cash reserves fall at Arecor
03 Feb
hVIVO signs human challenge trial contract with Inhalon Biopharma
03 Feb
AstraZeneca's Imfinzi set for go-ahead by EU to treat lung cancer
03 Feb
«
1
2
«
2024-11
2024-12
2025-01
2025-02
2025-03
»
Loading:
Login with Facebook
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In